Molecular genetic studies have pointed to a relationship between congenital lipodystrophy syndromes and some cardiac disorders. For instance, mutations in LMNA cause either lipodystrophy or cardiomyopathy, indicating that different mutations in the same gene can produce these clinical syndromes. The present authors describe a 10-year-old female with Berardinelli-Seip congenital complete lipodystrophy (MIM 606158) caused by homozygosity for a frameshift mutation in BSCL2. In addition to the typical attributes of complete lipodystrophy, this subject had hypertrophic cardiomyopathy diagnosed in the first year of her life; its progress has been followed with non-invasive imaging. The mechanism underlying the hypertrophic cardiomyopathy in complete lipodystrophy is unclear. It may result from a direct effect of the mutant gene or it might be secondary to the effects of hyperinsulinemia on cardiac development. The variability of the associated cardiomyopathy in patients with complete generalized lipodystrophy may be caused by differential effects of mutations in the same gene or of mutations in different genes which underlie the lipodystrophy phenotype.
Case 1: Progressive vomiting in a three-week-old infant A 20-day-old female infant was transferred from a peripheral hospital with progressive vomiting and weight loss. The infant was born to a 31-year-old primiparous mother at 37 weeks' gestation by spontaneous vaginal delivery. The pregnancy was uncomplicated, apart from a positive screen for group B streptococcus, which was adequately treated during labour. The infant's birth weight was approximately 3 kg.Vomiting began at seven days of age, when nystatin was started for treatment of oral thrush. The vomiting progressively became more frequent and projectile in nature. By the time of admission, at three weeks of age, the infant had projectile nonbilious vomiting that occurred 1 h to 2 h after every attempted feeding. She appeared hungry immediately after vomiting. The infant had been offered two different formulas (Enfamil [Mead Johnson Nutritionals, Ottawa, Ontario] and Goodstart [Nestlé Canada]), and minimal expressed breastmilk by bottle since birth. The formula changes did not result in symptomatic improvement. She was offered approximately 60 mL of feed every 2 h to 3 h. Her bowel movements were normal, apart from a few loose, nonbloody stools on the day of admission. Her parents reported that there had been four to five wet diapers per day before admission. The infant was otherwise healthy, with no fever, rash or systemic symptoms.Both parents were healthy and of Italian descent. Family history was not contributory.The infant's admission weight was 2180 g (25% less than her birth weight), with the clinical appearance of significant dehydration and malnutrition (little subcutaneous fat and muscle wasting). She was afebrile, with stable vital signs for her age, including a pulse rate of 120 beats/min after initial fluid resuscitation of 20 mL/kg of 0.9% saline followed by isotonic fluid at a maintenance rate. Her abdomen was soft, scaphoid and nontender, with no organomegaly. There were no palpable masses, including no palpable 'olive' when the baby was quiet. The remainder of the examination was normal, apart from slight oral thrush.Initial laboratory investigations revealed severe metabolic alkalosis with venous pH 7.64, PCO 2 50 mmHg, bicarbonate 54 mmol/L and base excess +26 mmol/L. Electrolytes were abnormal with serum sodium 119 mmol/L, potassium 4.7 mmol/L, chloride lower than 50 mmol/L and glucose 10.9 mmol/L. Both urea and creatinine concentrations were significantly elevated (blood urea nitrogen 22.7 mmol/L and creatinine 261 μmol/L). The infant's complete blood count was normal, apart from thrombocytosis (767×10 9 /L). Her urine pH was greater than 9.0 and specific gravity was 1.010 g/L; she had normal microscopy, except for 2+ protein.Her abdominal ultrasound revealed stomach contents passing through a nonhypertrophied pylorus that was seen to open and close normally. The infant's abdominal radiograph showed a small amount of gas in a single, mildly prominent structure in the mid-abdomen and a paucity of bowel gas in the remainder of the abd...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.